Clinical Trials Directory

Trials / Terminated

TerminatedNCT01556828

Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

Status
Terminated
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.

Conditions

Timeline

Start date
2011-06-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2012-03-16
Last updated
2016-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01556828. Inclusion in this directory is not an endorsement.